The development of protein farnesyltransferase inhibitors as signaling-based anticancer agents.

Progress in cell cycle research

Volumn 5, Issue , 2003, Pages 211-217

  Ohkanda, Junko ^a   Blaskovich, Michelle A ^a   Sebti, Saïd M ^a   Hamilton, Andrew D ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; P21(RAS) FARNESYL PROTEIN TRANSFERASE; P21(RAS) FARNESYL-PROTEIN TRANSFERASE; RAS PROTEIN; TRANSFERASE;

ANIMAL; CELL CYCLE; CHEMICAL STRUCTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ALKYL AND ARYL TRANSFERASES; ANIMALS; CELL CYCLE; ENZYME INHIBITORS; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; PROTEIN ISOPRENYLATION; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 0642347888     PISSN: 10872957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)